CVRS stock: buy or sell?

CVRS stock price: $4.27 0.00% At close on October 28th, 2019

Updated on:
October 28th, 2019


Shares of Corindus Vascular Robotics closed on October at $4.27 and remained constant a tight 0.00%.

Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures.

Should I buy CVRS stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Following a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at we prefer those that are simple but successful.

None of our preferred buy setups matches with Corindus Vascular Robotics stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Corindus Vascular Robotics stock a buy?

Banks and financial institutions post stock ratings everyday. Unfortunately, we couldn't detect any rating for CVRS stock for the last month.

CVRS stock analysis

Daily outlook

Corindus Vascular Robotics shares remained stable 0.00% to $4.27 on October.

Corindus Vascular Robotics ended on October at $4.27 and remained stable a tight 0.00%. From a daily perspective, CVRS is in a short term uptrend after plotting its last bottom ($4.25, on September) higher than the previous bottom, and its last top ($4.40, on October) also over the previous top. Now trading in between its last bottom and last top CVRS might consolidate in a plain range, waiting to break out over $4.40 or down under $4.25. On August CVRS price bounced up over the SMA of 100 days demonstrating to be a significant support for this stock.

CVRS stock chart (daily)

Weekly outlook

Corindus Vascular Robotics shares stayed stable 0.00% late October, ending at $4.27.

Corindus Vascular Robotics stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Since early January when CVRS stock price broke up the SMA40w line, it gained $3.22 (306.67%). Late February, SMA10w and SMA20w crossed up triggering a rise of 190.48%.

CVRS stock chart (weekly)

CVRS stock price history

CVRS IPO was on August 18th, 2014 at $3.15 per share1. Since then, CVRS stock grew a 35.60%, with an average of 7.10% per year. If you had invested right after CVRS's IPO a $1,000 in CVRS stock in 2014, it would worth $356.00 today.

1: Adjusted price after possible price splits or reverse-splits.

CVRS stock historical price chart

CVRS stock reached 52-week highs on October at $4.40, and all-time highs 2015-06-15 with a price of 4.58.

CVRS stock price target

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we have not detected any price forecast for Corindus Vascular Robotics stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

, when Corindus Vascular Robotics presented its last earnings report, it . As soon as we get its actual EPS from the earnings report, we will extend this report.
CVRS earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

Compared to 2017, last anual revenues report draw a superb increase of 11.72% to $10.78 million USD. Aligned with this, its profit margin (compared to sales) climbed to -324.54%, that is $-34.99 million.

Corindus Vascular Robotics fiscal year ends in December, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Corindus Vascular Robotics TTM sales up to September 2018 were $10.30 and income $-35.53 million dollars. When comparing this TTM figures with the last reported annuality, we can esteem Corindus Vascular Robotics business evolution since December 2018: Annual turnover up to September, compared to lastest yearly report, depreciated a rough -4.48%. Regarding profit margin, Corindus Vascular Robotics collapsed -20.43% to -324.54%

CVRS annual Sales and Income evolution
2013$0.90 M-$-14.69 M-1639.5%-
2014$36 M3,917.86%$0.00 M0.0%-100.00%
2014$2.98 M-91.71%$-24.54 M-822.7%0.00%
2015$2.73 M-8.51%$-28.76 M-1054.0%17.20%
2016$2.84 M4.14%$-33.08 M-1163.9%15.00%
2017$9.65 M239.55%$-34.12 M-353.6%3.16%
2018$11 M11.72%$-34.99 M-324.5%2.54%
TTM $10 M-4.48%$-35.53 M-345.0%1.53%

Quarterly financial results

Corindus Vascular Robotics reported $2.96 M in sales for 2018-Q3, a 77.66% improvement compared to previous quarter. Reported quarter earnings marked $-7.60 million with a profit margin of -256.76%. Profit margin rocketed a 338.37% compared to previous quarter when profit margin was -595.14%. When comparing revenues to same quarter last year, Corindus Vascular Robotics sales marked an outstanding growth and skyrocketed a 21.98%. Looking back to recent quarterly results, Corindus Vascular Robotics posted 2 positive quarters in a row.
CVRS quarterly Sales and Income evolution
2017-Q1$1 M-$-9.89 M-1272.8%-
2017-Q2$2 M190.86%$-8.41 M-372.1%-14.96%
2017-Q3$2 M7.30%$-7.85 M-323.8%-6.62%
2017-Q4$4 M72.78%$-7.97 M-190.2%1.50%
2018-Q1$1 M-64.56%$-10.05 M-676.8%26.08%
2018-Q2$2 M12.12%$-9.91 M-595.1%-1.40%
2018-Q3$3 M77.66%$-7.60 M-256.8%-23.35%
2018-Q4$5 M57.98%$-7.44 M-159.1%-2.11%

Corindus Vascular Robotics ownership

When you are planning to buy a company, it's always worth to have a look its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Corindus Vascular Robotics, of all outstanding shares are owned by its staff.

For a better context understanding, the next table shows ownership data compared to other related companies:

Market cap$0.0 M
Total shares0.0 M
Float shares0.0 M
  - Institutional holdings (%)0.0%
  - Insider holdings (%)0.0%
Shares in short selling0.0%

CVRS summary

Monday, October 28th, 2019
Day range$4.27 - $4.28
Previous close$4.27
Session gain0.00%
Average true range$0.01
50d mov avg$4.26
100d mov avg$3.65
200d mov avg$2.76
Daily patternlt06a
Weekly pattern lt06a

Corindus Vascular Robotics performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Corindus Vascular Robotics, the comparison is made against .
CVRSCorindus Vascular...78.66%96.77%288.18%

Corindus Vascular Robotics competitors

Unfortunately, we could not find any public company that could be defined as Corindus Vascular Robotics competitor. This doesn't mean Corindus Vascular Robotics does not have any competitor in the market, it's just we could not detected it.